{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:07:47Z","timestamp":1791846467149,"version":"4.3.4"},"reference-count":33,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":165,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p\/>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a complex reproductive\u2013endocrine disorder characterized by impaired folliculogenesis, anovulation, and hormonal imbalance. While PNX-14 is known as a hypothalamic peptide that modulates GnRH signaling, emerging evidence indicates its local ovarian expression, particularly in granulosa and luteal cells, suggesting potential peripheral roles in follicular development. This study aimed to evaluate the therapeutic potential of PNX-14 in a dehydroepiandrosterone (DHEA)-induced rat model of PCOS, with a focus on its potential peripheral effects on ovarian tissue. Female rats were divided into control, PCOS, and PCOS + PNX-14 (2.5, 5, or 30 nmol) groups. PCOS was induced by DHEA administration (60 mg\/kg\/day, s.c.) for 21 days. Vaginal cytology, hormone assays (FSH, LH, E2, P4, and testosterone), histological analysis, PCNA immunohistochemistry, and western blot were performed. DHEA-induced PCOS rats exhibited disrupted estrous cycles, suppressed gonadotropins and estradiol, and polycystic ovarian morphology with extensive follicular atresia and reduced PCNA expression. PNX-14 treatment, particularly at 5 nmol, significantly improved estrous cyclicity, restored primordial and antral follicle populations, reduced atretic and cystic follicles, and normalized PCNA levels in granulosa cells. Serum hormones showed trends toward recovery without consistent statistical significance after 3 days of treatment. This study provides the first in vivo evidence that peripheral administration of this peptide ameliorates key morphological and cellular features of PCOS in rats, primarily by enhancing granulosa cell proliferation and early folliculogenesis. These findings support further investigation into PNX-14 as a novel therapeutic candidate as a local ovarian modulator for PCOS, potentially offering disease-modifying effects beyond conventional symptom-targeted therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lay summary<\/jats:title>\n                    <jats:p>PCOS is a leading cause of infertility and affects millions of women worldwide. It disrupts normal egg development, causing hormonal imbalances and cyst formation in the ovaries. Current treatments mainly control symptoms but do not repair the ovary itself. We investigate PNX-14, a natural peptide present in the brain and ovary that supports early egg growth. We tested this peptide found in the brain and ovary that supports early egg growth, in a well-established rat model of PCOS. After three days of treatment, it improved ovarian structure and restored regular reproductive cycling. Importantly, it significantly reduced degenerating follicles, helping to preserve healthy early-stage follicles. These benefits occurred even though major blood hormone levels were largely unchanged, suggesting that this peptide acts locally within the ovary. This is the first in vivo evidence that it can directly counter key cellular and structural damage caused by PCOS. The findings highlight PNX-14 as a potential new therapy to protect ovarian health and improve fertility in people with PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/raf-25-0142","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:04:16Z","timestamp":1769605456000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-13","source":"Crossref","is-referenced-by-count":1,"title":["Phoenixin-14 ameliorates ovarian morphology in a DHEA-induced rat model of PCOS"],"prefix":"10.1530","volume":"7","author":[{"given":"Miray","family":"Berber","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonca","family":"Topal","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asligul","family":"Bulut","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulce","family":"Sevdar Cecen","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibe","family":"Goren","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Guney Eskiler","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulfiye","family":"Gul","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4969-3584","authenticated-orcid":true,"given":"Duygu","family":"Gok Yurtseven","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"2026070714093388300_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/19396368.2017.1296046","article-title":"Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome","volume":"63","author":"Bakhshalizadeh","year":"2017","journal-title":"Syst Biol Reprod Med"},{"key":"2026070714093388300_bib2","doi-asserted-by":"crossref","first-page":"8378","DOI":"10.3390\/ijms21218378","article-title":"Phoenixin: more than reproductive peptide","volume":"21","author":"Billert","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026070714093388300_bib3","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070714093388300_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623315570339","article-title":"Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears","volume":"43","author":"Cora","year":"2015","journal-title":"Toxicol Pathol"},{"key":"2026070714093388300_bib5","first-page":"3519","article-title":"Serum phoenixin-14 levels of women with polycystic ovary syndrome increase proportionally with BMI","volume":"27","author":"Cundubey","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026070714093388300_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"2026070714093388300_bib7","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/jc.2013-2040","article-title":"Renaming PCOS \u2013 a two-state solution","volume":"98","author":"Dunaif","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714093388300_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2026070714093388300_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1586\/17446651.2.2.215","article-title":"Growth factors and folliculogenesis in polycystic ovary patients","volume":"2","author":"Giovanni Artini","year":"2007","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2026070714093388300_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2026070714093388300_bib11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2020.05.101","article-title":"Levels of the neuropeptide phoenixin-14 and its receptor GRP173 in the hypothalamus, ovary and periovarian adipose tissue in rat model of polycystic ovary syndrome","volume":"528","author":"Kalamon","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"2026070714093388300_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fendo.2018.00735","article-title":"An improved dehydroepiandrosterone-induced rat model of polycystic ovary syndrome (PCOS): post-pubertal improve PCOS's features","volume":"9","author":"Kim","year":"2018","journal-title":"Front Endocrinol"},{"key":"2026070714093388300_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.repbio.2023.100827","article-title":"Expression and in vitro effect of phoenixin-14 on the porcine ovarian granulosa cells","volume":"24","author":"Kurowska","year":"2024","journal-title":"Reprod Biol"},{"key":"2026070714093388300_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.956500","article-title":"Regulation and physiological functions of phoenixin","volume":"9","author":"Liang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"2026070714093388300_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2010.02.015","article-title":"Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome","volume":"119","author":"Motta","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026070714093388300_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/REP-19-0025","article-title":"Effect of the neuropeptide phoenixin and its receptor GPR173 during folliculogenesis","volume":"158","author":"Nguyen","year":"2019","journal-title":"Reproduction"},{"key":"2026070714093388300_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70200","article-title":"Protective effects of phoenixin-14 administration against renal ischemia\/reperfusion injury in rats","volume":"39","author":"Oz","year":"2025","journal-title":"J Biochem Mol Toxicol"},{"key":"2026070714093388300_bib18","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/jpp\/rgac055","article-title":"Phoenixin 14 ameloriates pancreatic injury in streptozotocin-induced diabetic rats by alleviating oxidative burden","volume":"74","author":"Ozdemir-Kumral","year":"2022","journal-title":"J Pharm Pharmacol"},{"key":"2026070714093388300_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/rp.57.1.195","article-title":"Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization","volume":"57","author":"Richards","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"2026070714093388300_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2026070714093388300_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.anireprosci.2022.106931","article-title":"Canine cystic endometrial hyperplasia and pyometra may downregulate neuropeptide phoenixin and GPR173 receptor expression","volume":"238","author":"Rybska","year":"2022","journal-title":"Anim Reprod Sci"},{"key":"2026070714093388300_bib22","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/ijms19061726","article-title":"Phoenixin-A pleiotropic gut-brain peptide","volume":"19","author":"Schalla","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026070714093388300_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2017.08.004","article-title":"Phoenixin-14 injected intracerebroventricularly but not intraperitoneally stimulates food intake in rats","volume":"96","author":"Schalla","year":"2017","journal-title":"Peptides"},{"key":"2026070714093388300_bib24","doi-asserted-by":"crossref","first-page":"R489","DOI":"10.1152\/ajpregu.00191.2016","article-title":"Hypothalamic action of phoenixin to control reproductive hormone secretion in females: importance of the orphan G protein-coupled receptor Gpr173","volume":"311","author":"Stein","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026070714093388300_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.peptides.2018.06.005","article-title":"The phoenixins: from discovery of the hormone to identification of the receptor and potential physiologic actions","volume":"106","author":"Stein","year":"2018","journal-title":"Peptides"},{"key":"2026070714093388300_bib26","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome","volume":"41","author":"Stener-Victorin","year":"2020","journal-title":"Endocr Rev"},{"key":"2026070714093388300_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5694\/mja2.52432","article-title":"Summary of the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective","volume":"221","author":"Teede","year":"2024","journal-title":"Med J Aust"},{"key":"2026070714093388300_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cca.2017.06.013","article-title":"Phoenixin-14 concentrations are increased in association with luteinizing hormone and nesfatin-1 concentrations in women with polycystic ovary syndrome","volume":"471","author":"Ullah","year":"2017","journal-title":"Clin Chim Acta"},{"key":"2026070714093388300_bib29","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1111\/jog.15022","article-title":"Proliferating cell nuclear antigen presentation, as a marker of folliculogenesis, in the transplanted ovarian tissue","volume":"47","author":"Vatanparast","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"2026070714093388300_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1191759","article-title":"Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026070714093388300_bib31","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.2147\/DDDT.S258857","article-title":"Phoenixin 14 inhibits high-fat diet-induced non-alcoholic fatty liver disease in experimental mice","volume":"14","author":"Yang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"2026070714093388300_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/13813455.2021.1981946","article-title":"Phoenixin-14 protects cardiac damages in a streptozotocin-induced diabetes mice model through SIRT3","volume":"130","author":"Yao","year":"2024","journal-title":"Arch Physiol Biochem"},{"key":"2026070714093388300_bib33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2826.2012.02381.x","article-title":"A novel reproductive peptide, phoenixin","volume":"25","author":"Yosten","year":"2013","journal-title":"J Neuroendocrinol"}],"container-title":["Reproduction and Fertility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/raf.bioscientifica.com\/view\/journals\/raf\/7\/1\/RAF-25-0142.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/raf.bioscientifica.com\/downloadpdf\/journals\/raf\/7\/1\/RAF-25-0142.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article-pdf\/doi\/10.1530\/RAF-25-0142\/507983\/raf-25-0142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article-pdf\/doi\/10.1530\/RAF-25-0142\/507983\/raf-25-0142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:09:42Z","timestamp":1783447782000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article\/7\/1\/RAF250142\/75992\/Phoenixin-14-ameliorates-ovarian-morphology-in-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/raf-25-0142","relation":{},"ISSN":["2633-8386"],"issn-type":[{"value":"2633-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"RAF250142"}}